289 related articles for article (PubMed ID: 22207221)
1. Targeting cancer metabolism--aiming at a tumour's sweet-spot.
Jones NP; Schulze A
Drug Discov Today; 2012 Mar; 17(5-6):232-41. PubMed ID: 22207221
[TBL] [Abstract][Full Text] [Related]
2. Targeting survivin in cancer: the cell-signalling perspective.
Kanwar JR; Kamalapuram SK; Kanwar RK
Drug Discov Today; 2011 Jun; 16(11-12):485-94. PubMed ID: 21511051
[TBL] [Abstract][Full Text] [Related]
3. Tumor cell metabolism: cancer's Achilles' heel.
Kroemer G; Pouyssegur J
Cancer Cell; 2008 Jun; 13(6):472-82. PubMed ID: 18538731
[TBL] [Abstract][Full Text] [Related]
4. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.
Pathania D; Millard M; Neamati N
Adv Drug Deliv Rev; 2009 Nov; 61(14):1250-75. PubMed ID: 19716393
[TBL] [Abstract][Full Text] [Related]
5. Targeting glucose metabolism: an emerging concept for anticancer therapy.
Madhok BM; Yeluri S; Perry SL; Hughes TA; Jayne DG
Am J Clin Oncol; 2011 Dec; 34(6):628-35. PubMed ID: 20805739
[TBL] [Abstract][Full Text] [Related]
6. The potential utility of PFKFB3 as a therapeutic target.
Bartrons R; Rodríguez-García A; Simon-Molas H; Castaño E; Manzano A; Navarro-Sabaté À
Expert Opin Ther Targets; 2018 Aug; 22(8):659-674. PubMed ID: 29985086
[TBL] [Abstract][Full Text] [Related]
7. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
Workman P
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
[TBL] [Abstract][Full Text] [Related]
8. Hopefully devoted to Q: targeting glutamine addiction in cancer.
Still ER; Yuneva MO
Br J Cancer; 2017 May; 116(11):1375-1381. PubMed ID: 28441384
[TBL] [Abstract][Full Text] [Related]
9. Drug target identification in sphingolipid metabolism by computational systems biology tools: metabolic control analysis and metabolic pathway analysis.
Ozbayraktar FB; Ulgen KO
J Biomed Inform; 2010 Aug; 43(4):537-49. PubMed ID: 20348024
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Pathway Inhibition in Liver Cancer.
Zarrinpar A
SLAS Technol; 2017 Jun; 22(3):237-244. PubMed ID: 28314110
[TBL] [Abstract][Full Text] [Related]
11. The theoretical basis of cancer-stem-cell-based therapeutics of cancer: can it be put into practice?
Sánchez-García I; Vicente-Dueñas C; Cobaleda C
Bioessays; 2007 Dec; 29(12):1269-80. PubMed ID: 18022789
[TBL] [Abstract][Full Text] [Related]
12. Targeting cancer with phosphodiesterase inhibitors.
Savai R; Pullamsetti SS; Banat GA; Weissmann N; Ghofrani HA; Grimminger F; Schermuly RT
Expert Opin Investig Drugs; 2010 Jan; 19(1):117-31. PubMed ID: 20001559
[TBL] [Abstract][Full Text] [Related]
13. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
[TBL] [Abstract][Full Text] [Related]
14. Advances in targeting the Hedgehog signaling pathway in cancer therapy.
Kiesslich T; Neureiter D
Expert Opin Ther Targets; 2012 Feb; 16(2):151-6. PubMed ID: 22233124
[TBL] [Abstract][Full Text] [Related]
15. Rational targeting of Notch signaling in cancer.
Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
[TBL] [Abstract][Full Text] [Related]
16. Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis.
Barger JF; Plas DR
Endocr Relat Cancer; 2010 Dec; 17(4):R287-304. PubMed ID: 20699334
[TBL] [Abstract][Full Text] [Related]
17. Targeting signal transduction pathways in colorectal cancer--more than skin deep.
Cohen SJ; Cohen RB; Meropol NJ
J Clin Oncol; 2005 Aug; 23(23):5374-85. PubMed ID: 15998904
[TBL] [Abstract][Full Text] [Related]
18. Targeting silibinin in the antiproliferative pathway.
Li L; Zeng J; Gao Y; He D
Expert Opin Investig Drugs; 2010 Feb; 19(2):243-55. PubMed ID: 20047507
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of drug inhibition of signalling molecules.
Sebolt-Leopold JS; English JM
Nature; 2006 May; 441(7092):457-62. PubMed ID: 16724058
[TBL] [Abstract][Full Text] [Related]
20. New developments in the discovery of small molecule Hedgehog pathway antagonists.
Tremblay MR; McGovern K; Read MA; Castro AC
Curr Opin Chem Biol; 2010 Jun; 14(3):428-35. PubMed ID: 20399136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
